The HPRT1 gene helps your cells recycle purines, natural building blocks used to make DNA and other key molecules. This gene plays an important role in keeping uric acid from building up too much. If it does not work properly, you may develop kidney stones or gout, and more disruptive variants can cause Lesch-Nyhan syndrome, a childhood condition that affects movement, learning, and behavior. HPRT1 is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, which are the parts of cells that do much of the work. Other genes mainly direct when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to go into this topic in more detail, you can find more in the LearnHub.
Overview
HPRT1Gene function
What if the gene works
The HPRT1 gene helps cells recycle purines, which are building blocks for DNA and RNA. This supports everyday cell function and helps keep uric acid levels more balanced.
Risk
What if the gene does not work
Variants in the HPRT1 gene can cause a spectrum from high uric acid with gout or kidney stones to Lesch-Nyhan syndrome, with movement problems and developmental differences. Milder or more severe variants often influence when symptoms start and severity.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the HPRT1 gene supports treatment with uric acid lowering drugs such as allopurinol or febuxostat. Doses are adjusted to avoid over lowering, which can raise the chance of xanthine stones. These medicines help gout and kidney complications, but current treatment does not correct the movement, learning, or behavior features.
Conditions associated with HPRT1
Gene function
What if the gene works
Your cells constantly reuse small chemical building blocks to stay efficient. The HPRT1 gene supports this recycling system by helping cells recover purines, which are needed for DNA and RNA. Understanding how the HPRT1 gene works in the body helps explain how cells save energy and keep a steady supply of these materials.
The HPRT1 gene helps cells recycle purines, which are building blocks used to make DNA and RNA. It turns small purine pieces into forms the body can use again.
By reusing these building blocks, this gene helps keep the cell’s nucleotide supply steady. Nucleotides are the small parts cells need to make DNA, RNA, and other essential molecules.
Recycling purines takes less energy than making them from the beginning. This supports smooth day to day cell activity across the body.
The HPRT1 gene helps direct purines back into reuse instead of letting all of them move into breakdown pathways. This supports balanced handling of everyday cell waste and renewal.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the HPRT1 gene can change the shape or stability of its enzyme, so the cell’s purine recycling step slows or stops. This is how HPRT1 gene variants affect enzyme activity at a cellular level. Some variants leave part of the enzyme working, while more severe variants nearly eliminate activity. That functional range often tracks with the HPRT1 related condition spectrum, from milder later-onset features to earlier, more pronounced symptoms.
How variants are linked to conditions
Pathogenic variants in the HPRT1 gene cause Lesch-Nyhan syndrome, an X-linked condition linked to high uric acid levels, movement problems, and behavior changes. Milder HPRT1 gene variants can lead to HPRT1-related hyperuricemia, often called Kelley-Seegmiller syndrome, which may show up as gout or kidney stones. In HPRT1 gene variants and Lesch-Nyhan syndrome, the severity can vary depending on the specific variant.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For HPRT1, risk is mainly shaped by whether an inherited gene change is present and whether the gene is on your only X chromosome, so boys and men are much more likely to develop the condition. A family history of an HPRT1-related condition raises the chance, while there is not enough evidence to say that lifestyle changes lower this genetic risk.
Inheritance of HPRT1 variants
HPRT1-related conditions are inherited in an X-linked pattern, which means the HPRT1 gene is carried on the X chromosome. In families asking how HPRT1 variants are inherited, a mother carrying a variant can pass it to sons or daughters, while a father with the variant passes it to all daughters and not to his sons. Boys and men are more often clearly affected because they usually have one X chromosome, while girls and women may be carriers and sometimes have milder features.
What does my HPRT1 result mean for my family?
HPRT1 changes are usually passed down in an X-linked pattern, so family members on the mother’s side may also carry the variant or be affected. Women who carry an HPRT1 variant often have no symptoms, while boys and men in the family are more likely to have health problems related to it. Close relatives may want to review the result with a genetics specialist to understand what it could mean across the family.
Genetic information
Genetic testing
How you find out about variants
To find changes in the HPRT1 gene, doctors use genetic testing on a blood sample, saliva sample, or cheek swab. This HPRT1 gene test for Lesch-Nyhan syndrome reads the gene’s DNA code to look for variants that can confirm the diagnosis in an affected person or clarify whether a family member carries the variant.
When should I consider getting a genetic test?
Genetic testing for the HPRT1 gene may be worth considering if a boy has very high uric acid, early kidney stones or gout, or movement and behavior problems that suggest Lesch-Nyhan syndrome. It can also help when these problems run in the family, especially through the mother’s side.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result may give a clear answer. For medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down or handle a drug differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way medications work. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug acts and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the HPRT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor. HPRT1 has been studied because very low enzyme activity can change how some thiopurine medicines are processed, but this has not led to routine prescribing guidelines.
History
The HPRT1 gene entered medical history through studies of Lesch-Nyhan syndrome in the 1960s, when doctors linked a striking pattern of neurological and metabolic symptoms to an inherited change on the X chromosome. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect a rare condition to a precise genetic cause. Building on this early work, scientists showed that HPRT1 could also serve as a useful marker in cell biology and early human genetics research. Because cells lacking normal HPRT1 behave differently in laboratory growth media, the gene became a practical tool in research long before modern DNA sequencing was routine. These studies helped shape broader methods for tracking inherited disease and studying human cells.